RCMT
RCM TECHNOLOGIES, INC.
Company overview
- Market capitalization
- $289.19M
- Employees
- 4,930
- Latest publication
- 2026-09-29
About RCM TECHNOLOGIES, INC.
RCM Technologies, Inc. engages in the provision of business and technology solutions in the United States, Canada, Puerto Rico, Europe, and Philippines. The company operates through three segments: Engineering; Specialty Health Care; and Life Sciences, Data and Solutions (LS&D). It offers engineering services, including project management engineering, integrated design engineering, transmission and distribution power delivery, engineering analysis, engineering-procurement-construction, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The company also provides long-term and short-term staffing, executive search, international recruitment, and placement solutions in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school staffing and recruitment, and telepractice. In addition, it offers enterprise business solutions, application development and support, IT infrastructure deployment and management, data solutions, digitization, human capital management solutions, as well as technology and business solutions for the life sciences industry and other specific verticals. The company serves aerospace/defense, educational institutions, energy, financial services, healthcare, life sciences, manufacturing and distribution, public sector, and technology. RCM Technologies, Inc. was incorporated in 1971 and is based in Pennsauken, New Jersey.
Financial statements
Income Quarterly
| Metric | Q2 20262026-07-04 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 93,816,000USD | 83,038,000USD | 86,476,000USD | 70,289,000USD | 78,166,000USD | 84,473,000USD | 76,912,000USD | 60,365,000USD |
| Cost Of Revenue | 69,734,000USD | 61,571,000USD | 62,198,000USD | 51,418,000USD | 56,290,000USD | 62,919,000USD | 55,343,000USD | 42,524,000USD |
| Gross Profit | 24,082,000USD | 21,467,000USD | 24,278,000USD | 18,871,000USD | 21,876,000USD | 21,554,000USD | 21,569,000USD | 17,841,000USD |
| Selling General Administrative | 15,568,000USD | 15,529,000USD | 15,753,000USD | 14,933,000USD | 15,275,000USD | 14,971,000USD | 16,025,000USD | 13,018,000USD |
| Total Operating Expenses | 16,126,000USD | 15,529,000USD | 78,505,000USD | 14,933,000USD | 15,275,000USD | 14,971,000USD | 15,284,000USD | 13,456,000USD |
| Operating Income | 7,956,000USD | 5,938,000USD | 7,971,000USD | 3,938,000USD | 6,601,000USD | 6,583,000USD | 6,285,000USD | 4,385,000USD |
| Total Other Income Expense Net | -736,000USD | -562,000USD | 4,000USD | -614,000USD | -929,000USD | -698,000USD | -516,000USD | -619,000USD |
| Net Interest Income | -744,000USD | -626,000USD | -784,000USD | -584,000USD | -650,000USD | -651,000USD | -987,000USD | -492,000USD |
| Income Before Tax | 7,220,000USD | 5,376,000USD | 7,191,000USD | 3,324,000USD | 5,672,000USD | 5,885,000USD | 5,769,000USD | 3,766,000USD |
| Income Tax Expense | 2,319,000USD | 1,532,000USD | — | 1,065,000USD | 1,887,000USD | 1,699,000USD | 2,902,000USD | 1,020,000USD |
| Net Income | 4,901,000USD | 3,844,000USD | 6,104,000USD | 2,259,000USD | 3,785,000USD | 4,186,000USD | 2,867,000USD | 2,746,000USD |
| Interest Expense | — | 626,000USD | 784,000USD | 584,000USD | 650,000USD | 651,000USD | 664,000USD | 492,000USD |
| Tax Provision | — | 1,532,000USD | 1,087,000USD | 1,065,000USD | 1,887,000USD | 1,699,000USD | 2,902,000USD | 1,020,000USD |
| Net Income From Continuing Ops | — | 3,844,000USD | 6,104,000USD | 2,259,000USD | 3,785,000USD | 4,186,000USD | 2,867,000USD | 2,746,000USD |
| Ebit | — | 6,002,000USD | — | 3,908,000USD | 6,322,000USD | 6,536,000USD | 6,433,000USD | 4,258,000USD |
| Ebitda | — | 6,556,000USD | — | 4,447,000USD | 6,723,000USD | 6,960,000USD | 7,387,000USD | 4,651,000USD |
| Depreciation And Amortization | — | 554,000USD | — | 539,000USD | 401,000USD | 424,000USD | 954,000USD | 393,000USD |
| Reconciled Depreciation | — | 554,000USD | 554,000USD | 539,000USD | 401,000USD | 424,000USD | 954,000USD | 438,000USD |
| Unclassified Operating Expenses | — | — | 62,752,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 319,404,000USD | 278,380,000USD | 263,237,000USD | 284,680,000USD | 203,875,000USD | 191,100,000USD | 200,352,000USD | 186,737,000USD |
| Cost Of Revenue | 233,379,000USD | 198,602,000USD | 186,541,000USD | 201,753,000USD | 150,751,000USD | 142,508,000USD | 151,042,000USD | 138,350,000USD |
| Gross Profit | 86,025,000USD | 79,778,000USD | 76,696,000USD | 82,927,000USD | 53,124,000USD | 48,592,000USD | 49,310,000USD | 48,387,000USD |
| Selling General Administrative | 60,932,000USD | 56,787,000USD | 52,215,000USD | 53,395,000USD | 42,019,000USD | 40,437,000USD | 40,757,000USD | 40,644,000USD |
| Total Operating Expenses | 60,932,000USD | 57,453,000USD | 53,004,000USD | 54,129,000USD | 38,988,000USD | 42,025,000USD | 42,324,000USD | 42,401,000USD |
| Operating Income | 25,093,000USD | 22,325,000USD | 23,692,000USD | 28,798,000USD | 14,136,000USD | 6,567,000USD | 5,415,000USD | 280,000USD |
| Interest Expense | 2,669,000USD | 2,215,000USD | 1,399,000USD | 370,000USD | 365,000USD | 1,695,000USD | 1,471,000USD | 590,000USD |
| Net Interest Income | -2,669,000USD | -2,538,000USD | -1,139,000USD | -370,000USD | -365,000USD | -1,756,000USD | -1,471,000USD | -590,000USD |
| Income Before Tax | 22,072,000USD | 20,190,000USD | 22,195,000USD | 28,480,000USD | 13,914,000USD | 4,822,000USD | 3,908,000USD | -245,000USD |
| Income Tax Expense | 5,738,000USD | 6,863,000USD | 5,364,000USD | 7,591,000USD | 2,925,000USD | 764,000USD | 1,193,000USD | -2,255,000USD |
| Tax Provision | 5,738,000USD | 6,863,000USD | 4,868,000USD | 7,591,000USD | 2,925,000USD | 764,000USD | 1,193,000USD | -2,255,000USD |
| Net Income | 16,334,000USD | 13,327,000USD | 16,831,000USD | 20,889,000USD | 10,989,000USD | 4,058,000USD | 2,715,000USD | 2,010,000USD |
| Net Income From Continuing Ops | 16,334,000USD | 13,327,000USD | 16,413,000USD | 20,889,000USD | 10,989,000USD | 4,058,000USD | 2,715,000USD | 2,010,000USD |
| Ebit | 24,741,000USD | 22,405,000USD | 23,594,000USD | 28,850,000USD | 14,279,000USD | 6,567,000USD | 6,986,000USD | 5,939,000USD |
| Ebitda | 27,826,000USD | 24,507,000USD | 24,808,000USD | 29,891,000USD | 15,381,000USD | 8,155,000USD | 8,553,000USD | 7,696,000USD |
| Depreciation And Amortization | 3,085,000USD | 2,102,000USD | 1,214,000USD | 1,041,000USD | 1,102,000USD | 1,588,000USD | 1,567,000USD | 1,757,000USD |
| Reconciled Depreciation | 1,918,000USD | 2,102,000USD | 2,205,000USD | 2,042,000USD | 1,102,000USD | 1,588,000USD | 1,567,000USD | 1,757,000USD |
| Total Other Income Expense Net | -3,021,000USD | -2,135,000USD | -1,497,000USD | -318,000USD | -222,000USD | -1,745,000USD | -1,507,000USD | -525,000USD |
| Non Operating Income Net Other | — | — | — | 52,000USD | 143,000USD | -1,745,000USD | -1,507,000USD | -525,000USD |
| Net Income Applicable To Common Shares | — | — | — | 20,889,000USD | 10,989,000USD | 4,058,000USD | 2,715,000USD | 2,010,000USD |
| Unclassified Operating Expenses | — | — | — | — | -3,031,000USD | 1,588,000USD | 1,567,000USD | 1,757,000USD |
| Research Development | — | — | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-07-04 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 134,006,000USD | 135,327,000USD | 134,397,000USD | 129,815,000USD | 135,586,000USD | 120,992,000USD | 132,077,000USD | 125,545,000USD |
| Cash And Equivalents | 6,585,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 100,360,000USD | 101,575,000USD | 99,886,000USD | 94,927,000USD | 100,709,000USD | 85,976,000USD | 97,038,000USD | 90,496,000USD |
| Other Current Assets | 5,682,000USD | 7,130,000USD | 7,704,000USD | 4,160,000USD | 3,988,000USD | 5,240,000USD | 7,034,000USD | 5,112,000USD |
| Total Liabilities | 85,184,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 52,183,000USD | 52,836,000USD | 53,884,000USD | 48,014,000USD | 54,490,000USD | 53,234,000USD | 53,633,000USD | 55,644,000USD |
| Total Stockholder Equity | 48,822,000USD | 44,284,000USD | 45,974,000USD | 41,378,000USD | 37,786,000USD | 34,600,000USD | 33,484,000USD | 30,040,000USD |
| Total Equity Including Noncontrolling Interest | 48,822,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 8,204,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 11,231,000USD | 11,340,000USD | 12,097,000USD | 12,332,000USD | 12,336,000USD | 12,511,000USD | 12,542,000USD | 12,085,000USD |
| Goodwill | 22,147,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 14,395,000USD | 24,815,000USD | 25,896,000USD | 26,520,000USD | 32,147,000USD | 33,836,000USD | 37,239,000USD | 39,740,000USD |
| Short Term Debt | 1,142,000USD | 2,004,000USD | — | 2,009,999USD | 1,831,000USD | 1,813,000USD | 1,744,000USD | 1,708,000USD |
| Common Stock | 904,000USD | 901,000USD | — | 898,000USD | 896,000USD | 895,000USD | 890,000USD | 890,000USD |
| Retained Earnings | 19,141,000USD | 14,240,000USD | 10,396,000USD | 4,292,000USD | 2,033,000USD | -1,752,000USD | -5,938,000USD | -8,805,000USD |
| Accumulated Other Comprehensive Income | -3,034,000USD | -2,959,000USD | — | -2,757,000USD | -2,723,000USD | -2,918,000USD | -2,920,000USD | -2,787,000USD |
| Total Liab | — | 91,043,000USD | 88,423,000USD | 88,437,000USD | 97,800,000USD | 86,392,000USD | 98,593,000USD | 95,505,000USD |
| Other Current Liab | — | 12,280,000USD | — | 13,007,000USD | 10,581,000USD | 12,793,000USD | 10,141,000USD | 11,934,000USD |
| Capital Stock | — | 901,000USD | 900,000USD | 898,000USD | 896,000USD | 895,000USD | 890,000USD | 890,000USD |
| Good Will | — | 22,147,000USD | 22,147,000USD | 22,147,000USD | 22,147,000USD | 22,147,000USD | 22,147,000USD | 22,147,000USD |
| Cash | — | 2,621,000USD | 2,922,000USD | 1,309,000USD | 5,472,000USD | 5,181,000USD | 4,729,000USD | 3,156,000USD |
| Cash And Short Term Investments | — | 2,621,000USD | — | 1,309,000USD | 5,472,000USD | 5,181,000USD | 4,729,000USD | 3,156,000USD |
| Current Deferred Revenue | — | 13,354,000USD | — | 6,230,000USD | 9,143,000USD | 4,519,000USD | 4,163,000USD | 2,042,000USD |
| Net Debt | — | 31,917,000USD | 21,751,000USD | 36,598,000USD | 35,143,000USD | 25,264,000USD | 37,449,000USD | 34,838,000USD |
| Short Long Term Debt Total | — | 34,538,000USD | — | 37,907,000USD | 40,615,000USD | 30,445,000USD | 42,178,000USD | 37,994,000USD |
| Long Term Debt | — | 28,801,000USD | 24,673,000USD | 31,535,000USD | 34,015,000USD | 23,414,000USD | 34,967,000USD | 30,477,000USD |
| Net Receivables | — | 91,824,000USD | 56,004,000USD | 89,458,000USD | 91,249,000USD | 75,555,000USD | 85,275,000USD | 82,228,000USD |
| Property Plant Equipment Gross | — | 15,498,000USD | 15,702,000USD | 15,867,000USD | 15,333,000USD | 15,106,000USD | 14,714,000USD | 15,287,000USD |
| Common Stock Shares Outstanding | — | 7,614,695shares | 7,351,400shares | 7,614,695shares | 7,537,787shares | 7,741,481shares | 7,733,142shares | 7,955,943shares |
| Non Current Assets Total | — | 33,751,999USD | 34,511,000USD | 34,888,000USD | 34,877,000USD | 35,016,000USD | 35,039,000USD | 35,049,000USD |
| Non Current Liabilities Total | — | 38,207,000USD | 34,539,000USD | 40,422,999USD | 43,310,000USD | 33,158,000USD | 44,960,000USD | 39,861,000USD |
| Non Currrent Assets Other | — | 258,999USD | — | 278,000USD | 259,000USD | 233,000USD | 230,000USD | 215,000USD |
| Net Working Capital | — | 48,739,000USD | 46,002,000USD | 46,913,000USD | 46,219,000USD | 32,742,000USD | 43,405,000USD | 34,852,000USD |
| Unclassified Non Current Liabilities | — | 9,406,000USD | 9,866,000USD | 8,887,999USD | 9,295,000USD | 9,744,000USD | 9,993,000USD | 7,713,000USD |
| Unclassified Equity | — | 31,201,000USD | 34,678,000USD | 38,047,000USD | 36,684,000USD | 37,480,000USD | 40,562,000USD | 39,852,000USD |
| Unclassified Current Assets | — | — | 33,256,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | — | 27,988,000USD | — | — | — | — | — |
| Intangible Assets | — | — | — | — | — | — | — | 547,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 1,671,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 134,397,000USD | 132,077,000USD | 120,484,000USD | 87,964,000USD | 72,852,000USD | 68,339,000USD | 96,173,000USD | 81,510,000USD |
| Other Current Assets | 7,704,000USD | 7,034,000USD | 4,637,000USD | 4,636,000USD | 2,486,000USD | 4,699,000USD | 9,050,000USD | 3,425,000USD |
| Total Liab | 88,423,000USD | 98,593,000USD | 94,694,000USD | 56,002,000USD | 46,883,000USD | 46,101,000USD | 63,770,000USD | 54,311,000USD |
| Total Stockholder Equity | 45,974,000USD | 33,484,000USD | 25,790,000USD | 31,962,000USD | 25,969,000USD | 22,238,000USD | 32,403,000USD | 27,199,000USD |
| Other Current Liab | 28,240,000USD | 10,141,000USD | 11,503,000USD | 13,495,000USD | 13,130,000USD | 13,377,000USD | 214,000USD | 10,713,000USD |
| Common Stock | 900,000USD | 890,000USD | 882,000USD | 863,000USD | 845,000USD | 811,000USD | 791,000USD | 778,000USD |
| Capital Stock | 900,000USD | 890,000USD | 882,000USD | 863,000USD | 845,000USD | 811,000USD | 791,000USD | 778,000USD |
| Retained Earnings | 10,396,000USD | -5,938,000USD | -19,265,000USD | -36,096,000USD | -56,985,000USD | -67,974,000USD | -59,105,000USD | -63,163,000USD |
| Good Will | 22,147,000USD | 22,147,000USD | 22,147,000USD | 22,147,000USD | 16,354,000USD | 16,354,000USD | 16,354,000USD | 17,532,000USD |
| Cash | 2,922,000USD | 4,729,000USD | 6,284,000USD | 339,000USD | 235,000USD | 734,000USD | 1,847,000USD | 482,000USD |
| Cash And Short Term Investments | 2,922,000USD | 4,729,000USD | 6,284,000USD | 339,000USD | 235,000USD | 734,000USD | 1,847,000USD | 482,000USD |
| Total Current Assets | 99,886,000USD | 97,038,000USD | 90,502,000USD | 59,017,000USD | 51,971,000USD | 43,934,000USD | 70,657,000USD | 58,811,000USD |
| Total Current Liabilities | 53,884,000USD | 53,633,000USD | 58,196,000USD | 40,424,000USD | 29,857,000USD | 28,741,000USD | 21,408,000USD | 23,188,000USD |
| Current Deferred Revenue | 14,761,000USD | 4,163,000USD | 1,881,000USD | 1,119,000USD | 3,418,000USD | 398,000USD | 7,843,000USD | 150,000USD |
| Net Debt | 22,974,000USD | 37,449,000USD | 27,714,000USD | 13,419,000USD | 17,988,000USD | 16,036,000USD | 39,473,000USD | 27,058,000USD |
| Short Term Debt | 843,000USD | 1,744,000USD | 926,000USD | 1,811,000USD | 1,939,000USD | 2,133,000USD | 2,449,000USD | 150,000USD |
| Short Long Term Debt Total | 25,896,000USD | 42,178,000USD | 33,998,000USD | 13,758,000USD | 18,223,000USD | 16,770,000USD | 41,320,000USD | 27,690,000USD |
| Long Term Debt | 24,673,000USD | 34,967,000USD | 30,804,000USD | 8,783,000USD | 14,151,000USD | 11,890,000USD | 34,761,000USD | 27,540,000USD |
| Net Receivables | 89,260,000USD | 85,275,000USD | 79,581,000USD | 54,042,000USD | 49,250,000USD | 38,501,000USD | 64,666,000USD | 54,904,000USD |
| Accounts Payable | 9,649,000USD | 37,239,000USD | 43,556,000USD | 23,914,000USD | 11,370,000USD | 12,397,000USD | 10,772,000USD | 12,475,000USD |
| Property Plant Equipment Net | 12,097,000USD | 12,542,000USD | 6,784,000USD | 5,764,000USD | 3,816,000USD | 4,488,000USD | 8,537,000USD | 3,485,000USD |
| Property Plant Equipment Gross | 15,702,000USD | 14,714,000USD | 9,140,000USD | 8,296,000USD | 1,939,000USD | 2,078,000USD | 8,537,000USD | 3,485,000USD |
| Accumulated Other Comprehensive Income | -2,814,000USD | -2,920,000USD | -2,813,000USD | -2,863,000USD | -2,699,000USD | -2,550,000USD | -2,748,000USD | -2,755,000USD |
| Common Stock Shares Outstanding | 7,614,695shares | 7,939,381shares | 8,592,572shares | 10,442,176shares | 11,625,101shares | 12,152,042shares | 12,972,153shares | 12,340,909shares |
| Non Current Assets Total | 34,511,000USD | 35,039,000USD | 29,982,000USD | 28,948,000USD | 20,881,000USD | 24,406,000USD | 25,516,000USD | 22,699,000USD |
| Non Current Liabilities Total | 34,539,000USD | 44,960,000USD | 36,498,000USD | 15,578,000USD | 17,026,000USD | 17,360,000USD | 42,362,000USD | 31,123,000USD |
| Non Currrent Assets Other | 261,000USD | 230,000USD | 313,000USD | 173,000USD | 176,000USD | 169,000USD | 209,000USD | 214,000USD |
| Net Working Capital | 46,002,000USD | 43,405,000USD | 32,306,000USD | 18,593,000USD | 22,114,000USD | 15,193,000USD | 49,249,000USD | 35,623,000USD |
| Unclassified Non Current Liabilities | 9,866,000USD | 9,993,000USD | 4,023,000USD | 1,194,000USD | — | -2,829,000USD | -2,714,000USD | -3,185,000USD |
| Unclassified Equity | 36,592,000USD | 40,562,000USD | 46,104,000USD | 113,015,000USD | 110,223,000USD | 108,357,000USD | 107,661,000USD | 106,548,000USD |
| Intangible Assets | — | — | 683,000USD | 864,000USD | — | 95,000USD | 416,000USD | 743,000USD |
| Inventory | — | — | 1USD | — | -1,010,000USD | -2,494,000USD | -4,906,000USD | 1USD |
| Non Current Liabilities Other | — | — | 1,671,000USD | 1,970,000USD | 2,231,000USD | 2,464,000USD | 6,824,000USD | 3,185,000USD |
| Other Liab | — | — | — | 3,631,000USD | 742,000USD | 5,470,000USD | 3,491,000USD | 3,583,000USD |
| Other Assets | — | — | — | -1,000USD | 711,000USD | -1,000USD | 209,000USD | 939,000USD |
| Treasury Stock | — | — | — | -43,820,000USD | -26,260,000USD | -17,217,000USD | -14,987,000USD | -14,987,000USD |
| Net Tangible Assets | — | — | — | 8,951,000USD | 9,615,000USD | 22,238,000USD | 15,633,000USD | 8,924,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 365,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | 3,300,000USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | — | -4,906,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-07-04 · USD |
|---|---|
| Depreciation | 1,112,000USD |
| Stock Based Compensation | 1,832,000USD |
| Change To Liabilities | 4,952,000USD |
| Change In Working Capital | 9,043,000USD |
| Operating Cash Flow | 13,540,000USD |
| Capital Expenditures | -201,000USD |
| Investing Cash Flow | -201,000USD |
| Net Debt Issuance | -473,000USD |
| Common Stock Issuance | 308,000USD |
| Net Common Stock Issuance | -6,657,000USD |
| Unclassified Financing Cash Flow | -2,450,000USD |
| Financing Cash Flow | -9,272,000USD |
| Effect Of Forex Changes On Cash | -404,000USD |
| Change In Cash | 3,663,000USD |
| End Cash Flow | 6,585,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 3,844,000USD | 6,104,000USD | 2,259,000USD | 3,785,000USD | 4,186,000USD | 2,867,000USD | 2,746,000USD | 3,762,000USD |
| Depreciation | 554,000USD | 554,000USD | 539,000USD | 401,000USD | 424,000USD | 954,000USD | 438,000USD | 378,000USD |
| Stock Based Compensation | 1,008,000USD | 793,000USD | 1,033,000USD | 1,133,000USD | 773,000USD | 710,000USD | 767,000USD | 752,000USD |
| Other Non Cash Items | 301,000USD | 375,000USD | 253,000USD | 1,405,000USD | 1,040,000USD | -1,530,000USD | 253,000USD | 264,000USD |
| Change To Account Receivables | -3,892,000USD | — | 515,000USD | -15,322,000USD | 9,558,000USD | -2,064,000USD | -9,033,000USD | 6,628,000USD |
| Change In Working Capital | -3,037,000USD | 1,430,000USD | -5,346,000USD | -13,459,000USD | 11,015,000USD | -7,197,000USD | -8,598,000USD | 521,000USD |
| Total Cash From Operating Activities | 2,670,000USD | 11,445,000USD | -1,262,000USD | -7,878,000USD | 16,660,000USD | -1,637,000USD | -4,344,000USD | 5,725,000USD |
| Capital Expenditures | -97,000USD | -197,000USD | -498,000USD | -473,000USD | -427,000USD | -983,000USD | -522,000USD | -398,000USD |
| Free Cash Flow | 2,573,000USD | 11,248,000USD | -1,760,000USD | -8,351,000USD | 16,233,000USD | -2,620,000USD | -4,866,000USD | 5,327,000USD |
| Total Cashflows From Investing Activities | -97,000USD | — | -498,000USD | -473,000USD | -427,000USD | -983,000USD | -522,000USD | -398,000USD |
| Net Borrowings | 3,893,000USD | -7,111,000USD | -2,713,000USD | 10,417,000USD | -11,737,000USD | 4,306,000USD | 6,421,000USD | — |
| Total Cash From Financing Activities | -2,504,000USD | -9,567,000USD | -2,379,000USD | 8,491,000USD | -15,583,000USD | 4,307,000USD | 4,375,000USD | -3,796,000USD |
| Sale Purchase Of Stock | -6,688,000USD | -3,182,000USD | 988,000USD | -1,927,000USD | -3,188,000USD | 1,000USD | -2,410,000USD | -5,391,000USD |
| Change In Cash | -301,000USD | 1,613,000USD | -4,163,000USD | 291,000USD | 452,000USD | 1,573,000USD | -324,000USD | 1,381,000USD |
| Begin Period Cash Flow | 2,922,000USD | 1,309,000USD | 5,472,000USD | 5,181,000USD | 4,729,000USD | 3,156,000USD | 3,480,000USD | 2,099,000USD |
| End Period Cash Flow | 2,621,000USD | 2,922,000USD | 1,309,000USD | 5,472,000USD | 5,181,000USD | 4,729,000USD | 3,156,000USD | 3,480,000USD |
| Other Cashflows From Investing Activities | -97,000USD | — | -971,000USD | — | -427,000USD | -983,000USD | — | — |
| Other Cashflows From Financing Activities | -17,000USD | — | 334,000USD | 1,000USD | -939,000USD | 4,306,000USD | 364,000USD | -1,317,000USD |
| Unclassified Operating Cash Flow | — | 2,189,000USD | — | -1,143,000USD | — | 2,559,000USD | — | — |
| Investments | — | — | -498,000USD | -473,000USD | -427,000USD | -983,000USD | -522,000USD | -398,000USD |
| Unclassified Investing Cash Flow | — | — | 1,469,000USD | — | — | 1,966,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -4,306,000USD | — | 2,912,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 16,334,000USD | 13,327,000USD | 16,831,000USD | 20,889,000USD | 10,989,000USD | -8,869,000USD | 4,058,000USD | 2,715,000USD |
| Depreciation | 1,918,000USD | 2,102,000USD | 2,133,000USD | 2,042,000USD | 1,102,000USD | 1,386,000USD | 1,588,000USD | 1,567,000USD |
| Stock Based Compensation | 3,732,000USD | 2,864,000USD | 2,092,000USD | 1,582,000USD | 1,358,000USD | 1,108,000USD | 806,000USD | 544,000USD |
| Other Non Cash Items | 2,073,000USD | -779,000USD | 55,000USD | -1,139,000USD | -3,212,000USD | 10,287,000USD | 383,000USD | 1,153,000USD |
| Change To Account Receivables | -4,152,000USD | -7,271,000USD | -20,576,000USD | -1,509,000USD | -14,710,000USD | 15,947,000USD | -7,626,000USD | -7,681,000USD |
| Change In Working Capital | -6,360,000USD | -14,050,000USD | -8,670,000USD | 3,012,000USD | -11,864,000USD | 25,003,000USD | -12,717,000USD | -7,473,000USD |
| Total Cash From Operating Activities | 18,965,000USD | 6,170,000USD | 12,482,000USD | 28,440,000USD | 915,000USD | 25,203,000USD | -4,778,000USD | -64,000USD |
| Capital Expenditures | -1,595,000USD | -2,572,000USD | -2,931,000USD | -889,000USD | -568,000USD | -460,000USD | -367,000USD | -1,518,000USD |
| Free Cash Flow | 17,370,000USD | 3,598,000USD | 9,551,000USD | 27,551,000USD | 347,000USD | 24,743,000USD | -5,145,000USD | -1,582,000USD |
| Total Cashflows From Investing Activities | -1,595,000USD | -2,572,000USD | -2,536,000USD | -4,976,000USD | 6,291,000USD | -419,000USD | -363,000USD | -2,583,000USD |
| Net Borrowings | -11,144,000USD | 3,561,000USD | 21,558,000USD | -5,368,000USD | 2,261,000USD | -25,101,000USD | 7,222,000USD | 261,000USD |
| Total Cash From Financing Activities | -19,038,000USD | -4,828,000USD | -3,852,000USD | -23,128,000USD | -7,554,000USD | -25,632,000USD | 6,627,000USD | 346,000USD |
| Sale Purchase Of Stock | -7,359,000USD | -9,117,000USD | -25,773,000USD | -17,560,000USD | -9,043,000USD | -2,230,000USD | 321,000USD | 385,000USD |
| Change In Cash | -1,807,000USD | -1,555,000USD | 5,945,000USD | 104,000USD | -499,000USD | -1,113,000USD | 1,365,000USD | -2,369,000USD |
| Begin Period Cash Flow | 4,729,000USD | 6,284,000USD | 339,000USD | 235,000USD | 734,000USD | 1,847,000USD | 482,000USD | 2,851,000USD |
| End Period Cash Flow | 2,922,000USD | 4,729,000USD | 6,284,000USD | 339,000USD | 235,000USD | 734,000USD | 1,847,000USD | 482,000USD |
| Other Cashflows From Investing Activities | -1,595,000USD | -2,572,000USD | 395,000USD | 63,000USD | 6,859,000USD | 41,000USD | 4,000USD | 1,000USD |
| Other Cashflows From Financing Activities | -1,150,000USD | 728,000USD | 363,000USD | 308,000USD | -357,000USD | -137,000USD | -277,000USD | 85,000USD |
| Unclassified Operating Cash Flow | 1,268,000USD | 2,706,000USD | — | 2,054,000USD | 2,542,000USD | -3,712,000USD | 1,104,000USD | 1,430,000USD |
| Unclassified Investing Cash Flow | 1,595,000USD | 5,144,000USD | 4,847,000USD | — | -6,291,000USD | — | — | 1,517,000USD |
| Investments | — | -2,572,000USD | -4,847,000USD | -4,820,000USD | 6,291,000USD | -419,000USD | -363,000USD | -2,583,000USD |
| Dividends Paid | — | — | -43,116,000USD | -408,000USD | -137,000USD | -4,251,999USD | -12,000USD | -6,000USD |
| Unclassified Financing Cash Flow | — | — | 43,116,000USD | — | — | 6,087,999USD | — | — |
| Change To Liabilities | — | — | — | 2,620,000USD | 4,538,000USD | 1,639,000USD | -3,085,000USD | 1,021,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 336,000USD | -348,000USD | -848,000USD | 1,365,000USD | -2,369,000USD |
| Change To Inventory | — | — | — | — | -375,000USD | 4,660,000USD | -1,949,000USD | 903,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | -121,000USD | -68,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | Canada | 1,304,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 2,234,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Geography | PR | 1,760,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 77,740,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Product | Engineering Services | 26,137,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care | 48,104,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Product | Technology Service | 8,797,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Corporate | 0 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Engineering | 26,137,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Life Sciences Data Solutions | 8,797,000 | USD | 0001437749-26-017057 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Specialty Health Care | 48,104,000 | USD | 0001437749-26-017057 |
| Q4 2025Quarterly · 2025-12-31 | Product | Engineering Services | 30,409,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Health Care | 48,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Technology Service | 8,067,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Corporate | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Engineering | 30,404,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Life Sciences Data Solutions | 8,073,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Specialty Health Care | 47,999,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Canada | 7,535,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 15,319,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Geography | PR | 6,363,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 290,187,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Product | Engineering Services | 120,486,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Product | Health Care | 164,104,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 1,700,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Product | Technology Service | 34,814,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Segment | Corporate | 0 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Segment | Engineering | 120,486,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Segment | Life Sciences Data Solutions | 34,814,000 | USD | 0001437749-26-011236 |
| FY 2025Yearly · 2025-12-31 | Segment | Specialty Health Care | 164,104,000 | USD | 0001437749-26-011236 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Canada | 1,749,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 5,643,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Geography | PR | 1,523,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 61,374,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Product | Engineering Services | 31,414,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Product | Health Care | 29,999,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Product | Technology Service | 8,876,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Corporate | 0 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Engineering | 31,419,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Life Sciences Data Solutions | 8,870,000 | USD | 0001437749-25-033607 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Specialty Health Care | 30,000,000 | USD | 0001437749-25-033607 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Canada | 1,943,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 1,453,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Geography | PH | 0 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Geography | PR | 1,544,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 73,226,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Product | Engineering Services | 26,521,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Product | Health Care | 42,822,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Product | Technology Service | 8,823,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Corporate | 0 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Engineering | 26,521,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Life Sciences Data Solutions | 8,823,000 | USD | 0001437749-25-025431 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Specialty Health Care | 42,822,000 | USD | 0001437749-25-025431 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Canada | 1,916,000 | USD | 0001437749-25-015505 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 2,112,000 | USD | 0001437749-25-015505 |
| Q1 2025Quarterly · 2025-03-31 | Geography | PH | 0 | USD | 0001437749-25-015505 |
| Q1 2025Quarterly · 2025-03-31 | Geography | PR | 1,607,000 | USD | 0001437749-25-015505 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 78,838,000 | USD | 0001437749-25-015505 |
| Q1 2025Quarterly · 2025-03-31 | Product | Engineering Services | 32,142,000 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care | 43,283,000 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Product | Technology Service | 9,048,000 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Corporate | 0 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Engineering | 32,142,000 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Life Sciences Data Solutions | 9,048,000 | USD | 0001437749-26-017057 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Specialty Health Care | 43,283,000 | USD | 0001437749-26-017057 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Canada | 2,214,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe | 2,252,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | PR | 1,429,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 71,017,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Engineering Services | 26,279,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Health Care | 41,011,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Technology Service | 9,622,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Corporate | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Engineering | 26,279,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Life Sciences Data Solutions | 9,622,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Specialty Health Care | 41,011,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Canada | 7,196,000 | USD | 0001437749-25-007557 |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 7,408,000 | USD | 0001437749-25-007557 |
| FY 2024Yearly · 2024-12-31 | Geography | PH | 0 | USD | 0001437749-25-007557 |
| FY 2024Yearly · 2024-12-31 | Geography | PR | 7,017,000 | USD | 0001437749-25-007557 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 256,759,000 | USD | 0001437749-25-007557 |
| FY 2024Yearly · 2024-12-31 | Product | Engineering Services | 96,459,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Product | Health Care | 142,679,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 1,700,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Product | Technology Service | 39,242,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Segment | Corporate | 0 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Segment | Engineering | 96,459,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Segment | Life Sciences Data Solutions | 39,242,000 | USD | 0001437749-26-011236 |
| FY 2024Yearly · 2024-12-31 | Segment | Specialty Health Care | 142,679,000 | USD | 0001437749-26-011236 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Canada | 1,895,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 1,580,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Geography | PR | 1,568,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 55,322,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Product | Engineering Services | 24,167,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Product | Health Care | 26,554,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Product | Technology Service | 9,644,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Corporate | 0 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Engineering | 24,167,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Life Sciences Data Solutions | 9,644,000 | USD | 0001437749-25-033607 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Specialty Health Care | 26,554,000 | USD | 0001437749-25-033607 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.